See up to 3 months of GKOS. The 7-day demo opens the 1M and 3M ranges and puts GKOS on your watchlist.
Start 7-day demoLatest GKOS insider trades
About GLAUKOS Corp (GKOS)
GLAUKOS Corp is an SEC registrant, filing under CIK 0001192448, classified as surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
GKOS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 23 | 111,368 | $19.78M |
| Option exercise | 14 | 185,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
GKOS insider transactions (Form 4)
69109 Form 4 filings on record, the earliest from Oct 16, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Open-market sale | Common Stock | 888 | $163.93 footnote F2 | $146K | ||
| Open-market sale | Common Stock | 327 | $164.78 footnote F4 | $54K | ||
| Open-market sale | Common Stock | 312 | $165.60 footnote F5 | $52K | ||
| ||||||
| Open-market sale | Common Stock | 167 | $151.70 footnote F2 | $25K | ||
| Open-market sale | Common Stock | 136 | $152.71 footnote F4 | $21K | ||
| Open-market sale | Common Stock | 229 | $154.24 footnote F5 | $35K | ||
| Open-market sale | Common Stock | 1,083 | $154.88 footnote F6 | $168K | ||
| ||||||
| Open-market sale | Common Stock | 103 | $163.20 footnote F2 | $17K | ||
| Open-market sale | Common Stock | 345 | $164.60 footnote F4 | $57K | ||
| Open-market sale | Common Stock | 191 | $166.20 footnote F5 | $32K | ||
| Open-market sale | Common Stock | 460 | $167.32 footnote F6 | $77K | ||
| Open-market sale | Common Stock | 120 | $168.38 footnote F7 | $20K | ||
| Open-market sale | Common Stock | 234 | $170.95 footnote F8 | $40K | ||
| Open-market sale | Common Stock | 4 | $172.00 footnote F9 | $688 | ||
| ||||||
| Open-market sale | Common Stock | 7,643 | $180.25 footnote F1 | $1.38M | ||
| Open-market sale | Common Stock | 6,091 | $181.19 footnote F3 | $1.10M | ||
| Open-market sale | Common Stock | 10 | $182.50 | $2K | ||
| ||||||
| Gilbert H. Kliman - Director | Option exercise | Common Stock | 2,500 | $25.77 | $64K | |
| Gilbert H. Kliman - Director | Open-market sale | Common Stock | 2,500 | $190.00 | $475K | |
| Gilbert H. Kliman - Director | Option exercise | Stock Option (Right to Buy) | 2,500 | $0.00 | - | |
| Joseph E. Gilliam - Officer | Option exercise | Common Stock | 10,000 | $48.46 | $485K | |
| Joseph E. Gilliam - Officer | Option exercise | Common Stock | 20,000 | $55.18 | $1.10M | |
| Joseph E. Gilliam - Officer | Option exercise | Common Stock | 20,000 | $55.18 | $1.10M | |
| Joseph E. Gilliam - Officer | Option exercise | Common Stock | 10,000 | $48.46 | $485K | |
| Joseph E. Gilliam - Officer | Open-market sale | Common Stock | 27,963 | $178.89 footnote F2 | $5.00M | |
| Joseph E. Gilliam - Officer | Open-market sale | Common Stock | 32,037 | $180.49 footnote F3 | $5.78M | |
| Joseph E. Gilliam - Officer | Option exercise | Stock Option (Right to Buy) | 20,000 | $0.00 | - | |
| Joseph E. Gilliam - Officer | Option exercise | Stock Option (Right to Buy) | 20,000 | $0.00 | - | |
| Joseph E. Gilliam - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Joseph E. Gilliam - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| ||||||
| Alex R. Thurman - Officer | Option exercise | Common Stock | 20,000 | $33.81 | $676K | |
| Alex R. Thurman - Officer | Open-market sale | Common Stock | 20,000 | $180.13 footnote F3 | $3.60M | |
| Alex R. Thurman - Officer | Option exercise | Stock Option (Right to Buy) | 20,000 footnote F4 | $0.00 | - | |
| ||||||
| Leana Wen - Director | Open-market sale | Common Stock | 525 | $167.63 | $88K | |
| Alex R. Thurman - Officer | Option exercise | Common Stock | 10,000 | $38.68 | $387K | |
| Alex R. Thurman - Officer | Open-market sale | Common Stock | 10,000 | $160.00 | $1.60M | |
| Alex R. Thurman - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 footnote F3 | $0.00 | - | |
| ||||||
| Alex R. Thurman - Officer | Option exercise | Common Stock | 10,000 | $38.68 | $387K | |
| Alex R. Thurman - Officer | Open-market sale | Common Stock | 10,000 | $155.00 | $1.55M | |
| Alex R. Thurman - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 footnote F3 | $0.00 | - | |
| ||||||
| Alex R. Thurman - Officer | Option exercise | Common Stock | 10,000 | $38.68 | $387K | |
| Alex R. Thurman - Officer | Open-market sale | Common Stock | 10,000 | $150.00 | $1.50M | |
| Alex R. Thurman - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 footnote F3 | $38.68 | $387K | |
| ||||||
| Open-market sale | Common Stock | 716 | $139.06 | $100K | ||
| Tax withholding / forfeiture | Common Stock | 4,059 footnote F1 | $142.57 | $579K | ||
| ||||||
| Joseph E. Gilliam - Officer | Tax withholding / forfeiture | Common Stock | 1,056 footnote F1 | $142.57 | $151K | |
| ||||||
| Tax withholding / forfeiture | Common Stock | 483 footnote F1 | $142.57 | $69K | ||
| ||||||
| Mark J. Foley | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| Leana Wen | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| Marc Stapley | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| Aimee S. Weisner | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| Gilbert H. Kliman | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| David F. Hoffmeister | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| Denice Torres | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| Open-market sale | Common Stock | 1,537 | $130.68 | $201K | ||
| Leana Wen | Grant or award | Common Stock | 1,878 footnote F1 | $0.00 | - | |
| Leana Wen | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| ||||||
| Aimee S. Weisner | Grant or award | Common Stock | 1,878 footnote F1 | $0.00 | - | |
| Aimee S. Weisner | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| ||||||
| Denice Torres | Grant or award | Common Stock | 1,878 footnote F1 | $0.00 | - | |
| Denice Torres | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| ||||||
| Mark J. Foley | Grant or award | Common Stock | 1,878 footnote F1 | $0.00 | - | |
| Mark J. Foley | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| ||||||
| David F. Hoffmeister | Grant or award | Common Stock | 1,878 footnote F1 | $0.00 | - | |
| David F. Hoffmeister | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| ||||||
| Gilbert H. Kliman | Grant or award | Common Stock | 1,878 footnote F1 | $0.00 | - | |
| Gilbert H. Kliman | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| ||||||
| Marc Stapley | Grant or award | Common Stock | 1,878 footnote F1 | $0.00 | - | |
| Marc Stapley | Grant or award | Stock Option (Right to Buy) | 2,987 | $0.00 | - | |
| ||||||
Recent GKOS Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Navratil Tomas | Officer | 1,527 | $251K | View on EDGAR | |
| Navratil Tomas | Officer | 1,615 |
GKOS insider trading FAQ
What is the latest insider trade for GKOS?
GLAUKOS Corp (GKOS) had 9 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for GKOS runs to 109 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying GKOS stock?
No insider purchases of GKOS were filed in the last 90 days.
How many insiders are selling GKOS stock?
23 insider sales of GKOS were filed in the last 90 days, totaling $19.78M.
Where can I see GKOS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects GKOS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Tomas Navratil view on EDGAR
- - Tomas Navratil view on EDGAR
- - Tomas Navratil view on EDGAR
- - Tomas Navratil view on EDGAR
- - Gilbert H. Kliman view on EDGAR
- - Joseph E. Gilliam view on EDGAR
- - Alex R. Thurman view on EDGAR
- - Leana Wen view on EDGAR
- - Alex R. Thurman view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where GKOS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow GKOS with a 7-day demo
- GKOS on your watchlist
- Every GKOS Form 4 filing on record
- Up to 3 months of GKOS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive